Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Japan
Sponsor: GlaxoSmithKline
Dermatitis, Atopic
United States, Argentina, Bulgaria, Canada, China +10 more
Sponsor: Sanofi
Gaucher's Disease Type I · Gaucher's Disease Type III
Argentina, Canada, France, Italy, Japan +5 more
Sponsor: Johns Hopkins University
Coronary Artery Disease
United States, Brazil, Japan
- A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Active Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Locally Advanced or Metastatic Malignant Solid Tumors
United States, Canada, Japan
- A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid TumorsActive Not Recruiting
Sponsor: Takeda
Ovarian Cancer · Solid Tumors
Japan
- NS-050/NCNP-03 in Boys With DMD (Meteor50)Active Not Recruiting
Sponsor: NS Pharma, Inc.
Duchenne Muscular Dystrophy
United States, Canada, Japan, South Korea, Turkey (Türkiye)
- Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With AlhemoEnrolling By Invitation
Sponsor: Novo Nordisk A/S
Haemophilia A, Haemophilia B
Japan
- Pediatric Patients Aged 1 to 6 Years With APDSActive Not Recruiting
Sponsor: Pharming Technologies B.V.
APDS
United States, Japan, Portugal, Spain, United Kingdom
- Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With InhibitorsEnrolling By Invitation
Sponsor: Novo Nordisk A/S
Haemophilia A · Haemophilia B
Japan
- Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia (ITP)
United States, Argentina, Australia, Austria, Belgium +20 more
- PALbociclib CoLlaborative Adjuvant StudyActive Not Recruiting
Sponsor: Alliance Foundation Trials, LLC.
Breast Cancer
United States, Australia, Austria, Belgium, Canada +16 more
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Brazil, Canada, Chile +6 more
Sponsor: AstraZeneca
Breast Cancer
United States, Belgium, Brazil, Canada, China +12 more
Sponsor: Pfizer
Advanced Malignancies · Non-small-cell Lung Cancer
China, Japan, Russia, South Korea, Taiwan +1 more
Sponsor: Hoffmann-La Roche
Large B-Cell Lymphoma
United States, Argentina, Australia, Belgium, Brazil +16 more
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyActive Not Recruiting
Sponsor: Gilead Sciences
HIV-1-infection
United States, Argentina, Australia, Canada, Dominican Republic +9 more
- A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive Not Recruiting
Sponsor: Takeda
Ulcerative Colitis · Crohn's Disease
Japan
- Setrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaActive Not Recruiting
Sponsor: Ultragenyx Pharmaceutical Inc
Osteogenesis Imperfecta
Japan
Sponsor: Celgene
Multiple Myeloma
United States, Canada, Japan, Puerto Rico
Sponsor: Novo Nordisk A/S
Haemophilia A
Japan
- A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung CancerActive Not Recruiting
Sponsor: GlaxoSmithKline
Lung Cancer, Non-Small Cell
United States, Argentina, Belgium, Brazil, Finland +17 more
- Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THSRecruiting
Sponsor: Philip Morris Products S.A.
COPD · Smoking · Tobacco Use
United States, Bulgaria, Czechia, Germany, Japan +4 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Brazil +22 more
Sponsor: GlaxoSmithKline
Gastrointestinal Neoplasms
United States, Australia, Belgium, Brazil, Canada +14 more